Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02518334 · ClinicalTrials.gov registry record · NA
Wine Consumption and Glycemic Control
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02518334 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 14 participants.
The verdict
NCT02518334, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Many studies have reported that alcoholic beverage consumption, especially in the form of wine, reduces the risk of developing type 2 diabetes by as much as 40%. This association suggests that wine consumption may somehow improve the body's ability to control its blood glucose concentration. Indeed, it has been reported that when wine is consumed immediately prior to ingestion of glucose, the release of insulin is enhanced and blood glucose concentration is lowered. The mechanism of wine's effects on blood glucose concentration is unknown, but is likely related to its ethanol or antioxidant content. In this study, the investigators plan to test whether wine or plain ethanol (vodka) ingestion alters the control of blood glucose in subjects who have diabetes or pre-diabetes.
Interventions
- OTHER Alcohol consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02518334
The ClinicalTrials.gov registry entry for NCT02518334 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alcohol consumption is the first listed.
NCT02518334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02518334 about?
NCT02518334 is a clinical study titled "Wine Consumption and Glycemic Control". Many studies have reported that alcoholic beverage consumption, especially in the form of wine, reduces the risk of developing type 2 diabetes by as much as 40%. This association suggests that wine consumption may somehow improve the body's ability to control its blood glucose concentration. Indeed,...
What is the current status of trial NCT02518334?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2012-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02518334?
The interventions under investigation include: Alcohol consumption (OTHER).
Who is sponsoring clinical trial NCT02518334?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.